$30.33
-0.24-0.79%
Dern. MÀJ: Oct 2, 6:01 PM
$31.20
0.632.06%
vTv Therapeutics (VTVT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.94 | $0.24 | $-1.04 | $-0.98 |
| Actual | $-1.05 | $1.65 | $-0.58 | $-1.08 |
| Surprise | -11.7% | +587.5% | +44.2% | -10.2% |
| Revenue | ||||
| Estimate | $320000 | $12.0M | — | — |
| Actual | $0 | $36.8M | — | $0 |
| Surprise | -100.0% | +207.0% | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-1.16 | $-1.16 |
| Revenue | ||
| Consensus | $225000 | — |
| Trimestre Fiscal | Date de Déclaration | BPA Réel | BPA Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-1.05 | $-0.94 | -11.7 % |
| Q1 | May 13, 2026 | $1.65 | $0.24 | 587.5 % |
| Q4 | Mar 10, 2026 | $-0.58 | $-1.04 | 44.2 % |
| Q3 | Nov 6, 2025 | $-1.08 | $-0.98 | -10.2 % |
| Trimestre Fiscal | Date de Déclaration | Revenu Réel | Revenu Estimé | Surprendre % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $0 | $320.00K | -100.0 % |
| Q1 | May 13, 2026 | $36.84M | $12.00M | 207.0 % |
| Q4 | Mar 29, 2022 | $9.00K | $1.00M | -99.1 % |
| Q3 | Nov 9, 2021 | $3.00M | $2.80M | 7.14 % |